Jaguar Health (JAGX) Change in Cash (2014 - 2026)
Jaguar Health (JAGX) posted quarterly Change in Cash of $2.2 million for Q1 2026, up 196.54% year-over-year from $752681.4 in Q1 2025, and down 48.15% quarter-over-quarter from $4.3 million in Q4 2025.
Jaguar Health (JAGX) Change in Cash (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported Change in Cash for 13 consecutive years, with $2.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Cash rose 196.54% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $4.4 million (up 173.13% YoY), while the FY2025 annual figure was -$170000.0, down 111.09% from the prior year.
- Change in Cash retreated to $2.2 million in Q1 2026 per JAGX's latest filing, from $4.3 million in the prior quarter.
- Across five years, Change in Cash topped out at $8.9 million in Q1 2023 and bottomed at -$8.4 million in Q2 2022.
- Historically, Change in Cash has averaged -$411000.0 across 5 years, with a median of $405000.0 in 2022.
- Annual changes were most pronounced in 2022 — Change in Cash plunged 2397.63% — and 2023, when it surged 2097.04%.
- Jaguar Health's Change in Cash stood at -$5.1 million in 2022, then soared by 163.69% to $3.2 million in 2023, then tumbled by 262.41% to -$5.3 million in 2024, then soared by 181.74% to $4.3 million in 2025, then sank by 48.15% to $2.2 million in 2026.
- Business Quant data shows JAGX's Change in Cash at $2.2 million in Q1 2026, $4.3 million in Q4 2025, and $1.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Jaguar Health | 447,549.24 | -9.62 Mn | 19.11 Mn | 2.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.23 Mn |
| Dec 31, 2025 | 4.31 Mn |
| Sep 30, 2025 | 1.32 Mn |
| Jun 30, 2025 | -3.48 Mn |
| Mar 31, 2025 | -2.31 Mn |
| Dec 31, 2024 | -5.27 Mn |
| Sep 30, 2024 | -2.78 Mn |
| Jun 30, 2024 | 4.38 Mn |
| Mar 31, 2024 | 5.20 Mn |
| Dec 31, 2023 | 3.24 Mn |
| Sep 30, 2023 | -5.40 Mn |
| Jun 30, 2023 | -5.74 Mn |
| Mar 31, 2023 | 8.90 Mn |
| Dec 31, 2022 | -5.09 Mn |
| Sep 30, 2022 | 1.55 Mn |
| Jun 30, 2022 | -8.44 Mn |
| Mar 31, 2022 | 405,000.00 |
| Dec 31, 2021 | 4.68 Mn |
| Sep 30, 2021 | -19.54 Mn |
| Jun 30, 2021 | -338,000.00 |